MEDRYSONE
Health Topics Pharma News Home
Pharma News Home
FDA Approval Activities for this Drug HMS (medrysone ophthalmic suspension), 1% Allergan, NDA 16-624/S-041
HMS (medrysone ophthalmic suspension), 1% Allergan, NDA 16-624/S-041
For the latest approval information, please locate this drug using this index.